ZBH
Companies
Nyse American
Zimmer Biomet Holdings, Inc.
Health Care
$90.56
-$14.84 (-14.08%)
Price Chart
Overview
About ZBH
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Market Cap
$23.3B
Volume
166.5M
Avg. Volume
172.9M
P/E Ratio
11.952325
Dividend Yield
0.93%
Employees
17.5K
Company Information
Risk & Correlation Analysis
Market Correlation
0.70
Low Correlation
Volatility
Medium (0.22)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ZBH shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$23.3B
Volume166.5M
P/E Ratio11.95
Dividend Yield0.93%
Important Dates
Next Dividend
April 30, 2025Next Earnings
February 6, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025